**European Markets closed: Germany, Italy, Switzerland, Denmark, Norway, Sweden, Finland, Austria, Poland, Greece*** • Stryker said to plan bid for Smith & Nephew soon at 'significant premium" (Bloomberg) • Equinix board approves REIT conversion effective for taxable year beginning Jan 1 2015 • Novo Nordisk

off 80% since IPO) (All Things Digital) • Costco to pay investors $3B with special $7/shr dividend (total November comp sales +6% vs 5.5% ests) • Smith & Nephew to buy Healthpoint (private) for $782 million in cash (SN/ LN trading -0.90%) • ARM: Daily Mail speculation that Intel may bid for company (specula

ntained, committed to FY guidance (trading +0.22%) Hannover Re Q1 ahead driven by investment income, April renewals seen positive (trading +3.9%) Smith & Nephew 01 sales inline, EPS and EBIT ahead, guidance unchanged (trading +3.4%) BG Group in line with no surprises, confirms COMGAS stake sale (trading -3.

CIALIZATION Global Strategy and Commercial expertise in medical devces. aognostics. and biologics: leadership roles at ISTO Biologics, Orthofix, Smith & Nephew, Boston Scientific, Johnson & Johnson. and Abbott UPDATED EFTA00810555 u 1 Prostate Cancer - Novel Medicines EFTA00810556 Zuclomiphene: po

d, raising 2013 profit guidance (trading +0.21%) • RSA Insurance revs beat, EBIUT better, EPS ahead, on track to meet guidance (trading +0.60%) • Smith & Nephew revs light, EBIT miss, maintain outlook , positive tone for H2 (trading -0.50%) • Continental O2 revs & EBITDA inline, EPS beats, maintains revenue

uenom Inc. SI-Bone, Inc. Siemens Healthcare Diagnostics 5 EFTA_R1_01655697 EFTA02519484 SIGN Fracture Care International ' Silk Road Medical Smith & Nephew, Inc. Solana Surgical, LLC " Soma Access Systems LLC Somahlution, Inc. Somnetics International SomnoMed, Ltd. SonaCare Medical, LLC SonarMed,